|
|
 |
Molly S. McGlaughlin
Vice President Sales and Business Development
Cytovance Biologics
Molly McGlaughlin has 16 successful years of experience in Marketing and Business Development most recently leading Avecia Biotechnology Mammalian Cell Culture division. While at Avecia she led commercial activities for their synthetic DNA /siRNA , Peptide, and Microbial based products working on 30 plus customer programs.
She previously headed Patheon's expansion into the North American prescription market as a Senior Business Development Manager. Prior to joining Patheon Molly was a Senior Technical Representative and Director of Sales Training at Mallinckrodt Baker Inc.(now Tyco Healthcare).
She is a highly decorated Operation Iraqi Freedom Veteran with extensive leadership experience. She holds a BS in Biology and MeD in Adult Education and Organizational Performance. |
|
| |
|
|
 |
|
 |
Dr. Annie Van Broekhoven, Ph.D
VP Biologicals
Innogenetics Biologicals
Annie Van Broekhoven, PhD, is a chemist and obtained a PhD from the University of Antwerp
( Belgium ). Dr Van Broekhoven joined Innogenetics in 1993, after 12 years experience with UCL-Fina Research, on the cloning, expression and production of recombinant industrial enzymes. Before that she was a fellow of the Catholic University of Leuven, Belgium and of the Weizmann Institute, Rehovot , Israel .
She is a board member of Bio.be and a member of the Research Commission of the Belgian Federation of Chemistry, and has been appointed as professor since 1998 at the University of Antwerp . Formerly, she has served as a board member of Rhein Biotech NV and as a member of the Flemish Council for Research Policy. As of 2008, she was appointed Vice President Biologicals at Innogenetics. Dr Van Broekhoven is in charge of the Biologicals Division and oversees process development and manufacturing, QC, and QA. |
|
| |
|
|
|
|
 |
Rick Johnston
Co-Director, Biopharmaceutical Operations
University of California at Berkeley
Rick Johnston is the co-director of the University of California's Center
for Biopharmaceutical Operations (CBO). The CBO's partners with Industrial
and Government organizations to advance the art and practice of
biopharmaceutical production operations and logistics. Rick Johnston is a recognized expert on the subject of variability and risk in biological manufacturing. |
|
|
|
|
|
|
 |
Prof. Dr. Rolf G. Werner
Corporate Senior Vice President
Boehringer Ingelheim GmbH
Prof. Dr. Rolf G. Werner is Corporate Senior Vice President of the Corporate Division Biopharmaceuticals at Boehringer Ingelheim GmbH and responsible for the strategic orientation and the worldwide business of biopharmaceuticals.
He obtained his M.Sc. in biology at University of Tübingen in 1971. After his scientific work at the Max-Planck Institute for Molecular Genetics in Berlin he obtained his PhD at University of Tübingen in 1973.
In the same year he joined Boehringer Ingelheim at the Department of Biological Research and has been involved in antibiotic research. After a sabbatical in 1978 at the Massachusetts Institute of Technology in Cambridge, USA, he returned to Boehringer Ingelheim and became Head of Biopharmaceutical Manufacturing.
In 1990 he was appointed as professor at the Faculty of Biology at the University of Tübingen. He is member of the scientific board of the University of Stuttgart and the Fraunhofer Gesellschaft, member of the editorial board of the journal Drug Research and expert agrée for registrations of pharmaceuticals in France.
From 1998 to March 2000 he was head of the Industrial Biopharmaceutical Department at the Boehringer Ingelheim GmbH and therefore responsible for the development and manufacturing of biopharmaceuticals at various sites of Boehringer Ingelheim. According to the importance of this growing business this department became Corporate Division and Prof. Werner was promoted as the Corporate Senior Vice President in March 2000 |
|
| |
|
|
|
|
 |
Dr Suzanne Farid
The Advanced Centre for Biochemical Engineering
University College London, UK
Dr Suzanne Farid is a Senior Lecturer (Associate Professor) at The Advanced Centre for Biochemical Engineering at University College London, UK. She leads research into novel computer-aided decision-support tools for evaluating the potential of biotech investment opportunities in the face of inevitable uncertainty on process performance, timing and clinical success rates.
Industrial case studies focus on decisions in the areas of bioprocess design, capacity planning and R&D portfolio management. Examples include strategic, operational and tactical decisions in antibody production and in the emerging area of regenerative medicine. Techniques that are being explored and integrated include process economics, discrete-event simulation, multi-criteria decision making, combinatorial optimisation and uncertainty analysis. Suzanne has a strong publication record in international peer-reviewed journals, has been invited to write reviews and to give presentations at leading companies and conferences internationally.
Suzanne's current teaching activities include guiding students in their Bioprocess Plant Design Project, co-ordinating the department's post-experience MBI® training module on Bioprocess Validation and teaching on other modules on approaches to accelerating bioprocess development, process economics and R&D portfolio decisions. Suzanne obtained her Bachelor's degree in Biochemical Engineering and completed her Ph.D. degree in Biochemical Engineering with University College London and Lonza Biologics |
|
| |
|
|
|
READ MORE 
Future Technologies In Biologics Manufacturing -Transform Bioprocess Productivity And Over Come The Challenges Of Speed, Survival And Innovation
